Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 5/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 10/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 9/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9257397 | 0.91 | HDAC1 (0.43) | HDAC1HDAC2HDAC6HDAC4HSP90AB1 | |
| SCHEMBL9836909 | 0.83 | EGFR (0.54) | — | |
| SCHEMBL9837955 | 0.79 | HDAC6 (0.46) | HDAC1HDAC2HDAC6HDAC4HSP90AB1 | |
| SCHEMBL9837796 | 0.79 | HDAC1 (0.46) | HDAC1HDAC2HDAC6HDAC4HSP90AB1 | |
| SCHEMBL9837800 | 0.79 | HDAC1 (0.46) | HDAC1HDAC2HDAC6HDAC4HSP90AB1 | |
| SCHEMBL9396785 | 0.78 | MGMT (0.44) | HDAC1HDAC2 | |
| SCHEMBL9776572 | 0.77 | HDAC6 (0.49) | HDAC1HDAC2HDAC6HDAC4HSP90AB1 | |
| SCHEMBL9369791 | 0.76 | HDAC1 (0.48) | HDAC1HDAC2HDAC6HDAC4HSP90AB1 | |
| SCHEMBL9262368 | 0.76 | CHRNB2 (0.32) | HDAC1HDAC2 | |
| SCHEMBL9396758 | 0.76 | HDAC6 (0.44) | HDAC1HDAC6HDAC4HSP90AB1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0159264-B1 | ANTIVIRAL COMPOUNDS | MERCK & CO. INC. (US) | 1991-07-24 | — | — | EP | disclosed |
| US-4617304-A | VIRICIDE; HERPES | MERCK & CO., INC. (US) | 1986-10-14 | — | — | US | disclosed |
| EP-0159264-A2 | Antiviral compounds | MERCK & CO. INC. (US) | 1985-10-23 | — | — | EP | disclosed |